Distinguished U.S. Experts and Global Industry Leaders Join Newly Formed Advisory Board to Drive Strategic Growth and Innovation
BRISBANE, Australia and NEW YORK, March 11, 2025 /PRNewswire/ — WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring, today introduced its Advisory Board comprised of globally recognized experts in biotechnology, healthcare, regulatory affairs, and venture investment.
The formation of the six-member board is part of the company’s plan to accelerate the development of its Microwearable hydration sensor and U.S. launch timeline with a first focus on the professional and elite amateur sports market. WearOptimo’s first application of its technology, the hydration sensor, is the only wearable that enables genuine real-time continuous monitoring of hydration using a non-invasive skin-patch.
“Our Advisory Board represents an extraordinary convergence of scientific, regulatory, health, and commercial expertise that will help us to lead with innovation in the developing area of wearable technology for health monitoring,” said Dr. Mark Kendall, CEO and Founder of WearOptimo. “Our advisory board members will provide strategic insights and access to their expansive industry networks as we scale our Microwearable hydration sensor technology to its full potential globally with a focus on our near-term expansion into the U.S. Beyond the sports market, we plan to address health issues associated with hydration in the general wellness, defense, and high-risk industries sectors, such as mining. With our powerful technology platform, we will expand our applications to other biomarker monitoring opportunities and build a diverse product portfolio.”
WearOptimo’s Advisory Board members are:
The company’s vision and innovative IP portfolio have already secured commercial traction with Aspen Medical (serving mining and defense markets) and elite sports partnerships, including investment from Formula 1 champion Mark Webber. The addition of this world-class Advisory Board further strengthens WearOptimo’s position as a global leader in wearable health technology.
About WearOptimo
WearOptimo is a health technology company developing the next generation of wearable technology by leveraging AI to transform the way we approach hydration and biomarker monitoring. WearOptimo’s Microwearable hydration monitor is an AI-enhanced, ‘sticker-like’ skin-patch containing sensors in a minimally invasive, pain-free format that measure data points today’s typical wearables cannot collect. The powerful technology platform works by microelectrodes reaching just a hair’s width into the skin, directly detecting key body biosignals/biomarkers, which are then translated into real-time actionable wellness and health insights for the user. WearOptimo’s technology is at the forefront of real-time tech-enabled health monitoring, with applications spanning elite sports, military, and industrial sectors, where hydration is critical to performance and safety.
Please visit https://wearoptimo.com/ for more information and follow us on LinkedIn and Twitter (X).
*Photos of Board members are available on request
Company Contact:
Dr. Mark Kendall
mkendall@wearoptimo.com
Media Contacts:
Rachelle Babb, Ph.D. or Sean Naughton, Ph.D.
Russo Partners, LLC
rachelle.babb@russopartnersllc.com
sean.naughton@russopartnersllc.com
SOURCE WearOptimo
WASHINGTON & BERLIN--(BUSINESS WIRE)--Association of Medical Device Reprocessors issued the following statement: Friday’s unanimous verdict…
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patientswith Mild and Moderate-to-Severe Symptoms,…
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and…
Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time…
Data confirmed TX45’s tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in…
TORONTO, May 17, 2025 (GLOBE NEWSWIRE) -- Today, on DIPG Awareness Day, Brain Cancer Canada…